Health Canada recently approved lecanemab (brand name Leqembi®) to treat people with mild cognitive impairment or mild ...
SJP’s new lab-grown diamond line faces legal scrutiny over UK sanctions and traceability. Discover the hidden risks in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback